|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1998-1-30
|
|
pubmed:abstractText |
To estimate the frequency of and to identify possible risk factors involved with terminating an initial disease modifying antirheumatic drug (DMARD) therapy. We hypothesized that treatment termination depends not only on side effects and inefficacy but also on the therapeutic setting and the health beliefs of the patient.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
pubmed-author:AlteaEE,
pubmed-author:BrauerDD,
pubmed-author:EggensUU,
pubmed-author:Gromnica-IhleEE,
pubmed-author:HagemannDD,
pubmed-author:HauerRR,
pubmed-author:ListingJJ,
pubmed-author:MilleckDD,
pubmed-author:ReuterUU,
pubmed-author:SörensenHH,
pubmed-author:SchlittgenRR,
pubmed-author:ZiniGG
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2097-105
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9375866-Adult,
pubmed-meshheading:9375866-Antirheumatic Agents,
pubmed-meshheading:9375866-Arthritis, Rheumatoid,
pubmed-meshheading:9375866-Attitude to Health,
pubmed-meshheading:9375866-Cohort Studies,
pubmed-meshheading:9375866-Female,
pubmed-meshheading:9375866-Health Status,
pubmed-meshheading:9375866-Humans,
pubmed-meshheading:9375866-Male,
pubmed-meshheading:9375866-Methotrexate,
pubmed-meshheading:9375866-Middle Aged,
pubmed-meshheading:9375866-Probability,
pubmed-meshheading:9375866-Psychological Tests,
pubmed-meshheading:9375866-Risk Factors,
pubmed-meshheading:9375866-Sulfasalazine,
pubmed-meshheading:9375866-Treatment Outcome
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Importance of psychological well being and disease activity in termination of an initial DMARD therapy.
|
|
pubmed:affiliation |
Epidemiology Unit, German Rheumatism Research Center, Schlosspark Hospital, Berlin.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
